225 related articles for article (PubMed ID: 3459921)
1. Disposition of endogenous homocysteine by mouse fibroblast C3H/10T1/2 Cl 8 and the chemically transformed C3H/10T1/2 MCA Cl 16 cells following methotrexate exposure.
Ueland PM; Refsum H; Male R; Lillehaug JR
J Natl Cancer Inst; 1986 Jul; 77(1):283-9. PubMed ID: 3459921
[TBL] [Abstract][Full Text] [Related]
2. Disposition of homocysteine and S-3-deazaadenosylhomocysteine in cells exposed to 3-deazaadenosine.
Svardal A; Djurhuus R; Ueland PM
Mol Pharmacol; 1986 Aug; 30(2):154-8. PubMed ID: 3736540
[TBL] [Abstract][Full Text] [Related]
3. Differential effects on growth, homocysteine, and related compounds of two inhibitors of S-adenosylhomocysteine catabolism, 3-deazaadenosine, and 3-deazaaristeromycin, in C3H/10T1/2 cells.
Djurhuus R; Svardal AM; Ueland PM
Cancer Res; 1989 Jan; 49(2):324-30. PubMed ID: 2910451
[TBL] [Abstract][Full Text] [Related]
4. Disposition of homocysteine in rat hepatocytes and in nontransformed and malignant mouse embryo fibroblasts following exposure to inhibitors of S-adenosylhomocysteine catabolism.
Svardal AM; Djurhuus R; Refsum H; Ueland PM
Cancer Res; 1986 Oct; 46(10):5095-100. PubMed ID: 3756867
[TBL] [Abstract][Full Text] [Related]
5. Growth support and toxicity of homocysteine and its effects on methionine metabolism in non-transformed and chemically transformed C3H/10T1/2 cells.
Djurhuus R; Svardal AM; Ueland PM; Male R; Lillehaug JR
Carcinogenesis; 1988 Jan; 9(1):9-16. PubMed ID: 3335051
[TBL] [Abstract][Full Text] [Related]
6. Elucidation of the mechanism by which homocysteine potentiates the anti-vaccinia virus effects of the S-adenosylhomocysteine hydrolase inhibitor 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine.
Hasobe M; McKee JG; Ishii H; Cools M; Borchardt RT; De Clercq E
Mol Pharmacol; 1989 Sep; 36(3):490-6. PubMed ID: 2779528
[TBL] [Abstract][Full Text] [Related]
7. Folate depletion induced by methotrexate affects methionine synthase activity and its susceptibility to inactivation by nitrous oxide.
Fiskerstrand T; Ueland PM; Refsum H
J Pharmacol Exp Ther; 1997 Sep; 282(3):1305-11. PubMed ID: 9316839
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression and state of the c-myc oncogene in chemically and X-ray-transformed C3H/10T1/2 Cl 8 mouse embryo fibroblasts.
Billings PC; Shuin T; Lillehaug J; Miura T; Roy-Burman P; Landolph JR
Cancer Res; 1987 Jul; 47(14):3643-9. PubMed ID: 2439194
[TBL] [Abstract][Full Text] [Related]
9. Growth kinetic studies of methionine dependence in co-culture of monolayer and anchorage independent mouse cell lines.
Djurhuus R; Ueland PM
Anticancer Res; 1989; 9(6):1611-5. PubMed ID: 2627115
[TBL] [Abstract][Full Text] [Related]
10. Modulation of cellular interactions between C3H/10T1/2 cells and their transformed counterparts by phosphodiesterase inhibitors.
Bertram JS
Cancer Res; 1979 Sep; 39(9):3502-8. PubMed ID: 89899
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of the glucose-regulated gene encoding the Mr 78,000 glucose-regulated protein in chemically and radiation-transformed C3H 10T1/2 mouse embryo cells.
Patierno SR; Tuscano JM; Kim KS; Landolph JR; Lee AS
Cancer Res; 1987 Dec; 47(23):6220-4. PubMed ID: 2445468
[TBL] [Abstract][Full Text] [Related]
12. Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines.
Stern PH; Wallace CD; Hoffman RM
J Cell Physiol; 1984 Apr; 119(1):29-34. PubMed ID: 6707100
[TBL] [Abstract][Full Text] [Related]
13. Interaction between methotrexate, "rescue" agents and cell proliferation as modulators of homocysteine export from cells in culture.
Refsum H; Christensen B; Djurhuus R; Ueland PM
J Pharmacol Exp Ther; 1991 Aug; 258(2):559-66. PubMed ID: 1865358
[TBL] [Abstract][Full Text] [Related]
14. Reduced free-methionine in methionine-dependent SV40-transformed human fibroblasts synthesizing apparently normal amounts of methionine.
Stern PH; Mecham JO; Wallace CD; Hoffman RM
J Cell Physiol; 1983 Oct; 117(1):9-14. PubMed ID: 6311851
[TBL] [Abstract][Full Text] [Related]
15. Effect of methotrexate on homocysteine and other sulfur compounds in tissues of rats fed a normal or a defined, choline-deficient diet.
Svardal AM; Ueland PM; Berge RK; Aarsland A; Aarsaether N; Lønning PE; Refsum H
Cancer Chemother Pharmacol; 1988; 21(4):313-8. PubMed ID: 3370739
[TBL] [Abstract][Full Text] [Related]
16. Effects of 4'-modified analogs of aristeromycin on the metabolism of S-adenosyl-L-homocysteine in murine L929 cells.
Ault-Riché DB; Lee Y; Yuan CS; Hasobe M; Wolfe MS; Borcherding DR; Borchardt RT
Mol Pharmacol; 1993 Jun; 43(6):989-97. PubMed ID: 8316227
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of S-adenosylhomocysteine hydrolase by 9-beta-D-arabinofuranosyladenine in intact cells.
Helland S; Ueland PM
Cancer Res; 1982 Mar; 42(3):1130-6. PubMed ID: 7059972
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis and transmethylation metabolites in HL-60 cells.
Endresen PC; Loennechen T; Kildalsen H; Aarbakke J
J Pharmacol Exp Ther; 1996 Sep; 278(3):1318-24. PubMed ID: 8819518
[TBL] [Abstract][Full Text] [Related]
19. Amplification of the Ect2 proto-oncogene and over-expression of Ect2 mRNA and protein in nickel compound and methylcholanthrene-transformed 10T1/2 mouse fibroblast cell lines.
Clemens F; Verma R; Ramnath J; Landolph JR
Toxicol Appl Pharmacol; 2005 Aug; 206(2):138-49. PubMed ID: 15967202
[TBL] [Abstract][Full Text] [Related]
20. Cysteamine increases homocysteine export and glutathione content by independent mechanisms in C3H/10T1/2 cells.
Djurhuus R; Svardal AM; Ueland PM
Mol Pharmacol; 1990 Sep; 38(3):327-32. PubMed ID: 2402225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
